Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
PRIORITY PRESS - 7th World Congress of the World Institute of Pain (WIP 2014)
Pain Management: New Approaches in Opioid-Induced Constipation
Maastricht, The Netherlands / May 7-10, 2014
Maastricht - As the population ages, the incidence of chronic pain and resulting use of opioids for treatment is increasing. While opioids provide significant analgesic effect, their benefit is accompanied by common side effects. In an...
PHYSICIAN PERSPECTIVE - Viewpoint based on presentations from the 49th Annual Meeting of the European Association for the Study of the Liver (EASL)
New Direct-acting Antiviral Agents in the Treatment of Hepatitis C Genotype 1 Infection
London, UK / April 9-13, 2014
Guest Editor: Jordan J. Feld, MD, MPHToronto Centre for Liver DiseaseToronto Western HospitalFrancis Family Liver ClinicUniversity Health NetworkMcLauglin-Rotman Centre for Global HealthToronto,...
PRIORITY PRESS - Digestive Disease Week (DDW 2014)
Optimizing Therapy with Biologic Agents in Inflammatory Bowel Disease
Chicago, Illinois / May 3-6, 2014
Chicago - Oral and poster presentations at DDW 2014 reflected the changes that have evolved in the approach to treatment of inflammatory bowel disease as new data have been accumulated on the use of the tumor necrosis factor alpha (TNF)...
PRIORITY PRESS - 2014 Genitourinary Cancers Symposium
Cardiovascular Risk with ADT for Advanced Prostate Cancer
San Francisco, California / January 30-February 1, 2014
San Francisco - The principal goal of androgen deprivation therapy (ADT) is to reduce testosterone to castrate levels, thereby depriving prostate cancer cells of their key growth substrate. However, several studies have shown that ADT...
PRIORITY PRESS - 23rd Annual Canadian Conference on HIV/AIDS Research (CAHR)
Global Gains in the HIV Epidemic: Intensified and Simplified Treatment Regimens
St. John’s, Newfoundland and Labrador / May 1-4, 2014
St. John’s - Since the mid 90s, there has been a virtual explosion of novel antiretroviral therapies (ART) targeting HIV replication along multiple pathways. This has led to the development of potent new combinations of ARTs that are...
MEDI-NEWS - Based on Guidelines Prepared by the Meningococcal B Pilot Project Task Group
Young Infants and the Multi-Component Serogroup B Vaccine: New NACI Recommendations for Healthcare Professionals
March 26, 2014
Invasive meningococcal disease (IMD) is an acute and serious infection caused by the bacterium Neisseria meningitidis. In Canada, 5 serogroups are responsible for IMD, of which serogroup B is now the most prevalent, especially among infants...
PRIORITY PRESS - 7th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)
New Treatment Strategies for Prophylaxis in Severe Hemophilia: Moving from Clinical Trials into Real World Practice
Brussels, Belgium / February 26-28, 2014
Brussels - The focus of care in hemophilia A and B has shifted from the management of acute bleeding episodes (on-demand therapy) toward prophylaxis to prevent bleeding episodes and disease sequelae. Currently, hemophilia A patients...
PHYSICIAN PERSPECTIVE - Viewpoint based on current literature and presentations from the 19th Canadian Digestive Disease Week (CDDW) & 8th Annual CASL Winter Meeting
Update on Bowel Preparation Agents: Considering Efficacy, Tolerability and Safety for Optimal Compliance
Toronto, Ontario / February 8-11, 2014
Guest Editors:Stephen VannerProfessor of Medicine and PhysiologyQueen’s UniversityKingston, Ontario Lawrence HookeyAssociate Professor of MedicineQueen’s UniversityKingston, Ontario Introduction The effectiveness of...
MEDICAL FRONTIERS - 9th Congress of the European Crohn's and colitis Organisation (ECCO-IBD 2014)
New Insights into Strategies for Management of Crohn’s Disease and Ulcerative Colitis
Copenhagen, Denmark / February 20-22, 2014
Copenhagen - Numerous clinical trials have demonstrated the therapeutic value of treatment with monoclonal anti-TNF-a antibodies such as infliximab and adalimumab in luminal and/or fistulizing Crohn’s disease or ulcerative colitis,...